Reprogenetics laboratories were the first in the United States and Europe to use Next Generation Sequencing (NGS) for the purpose of identifying embryos with the greatest potential to produce a viable pregnancy. The first baby using this technique was born in 2013 after embryo analysis undertaken by Reprogenetics.
A new technique called Karyomapping, which allows embryos to be tested for serious inherited conditions, is now available through Reprogenetics. The technique has been fully validated and offers significant advantages over other methods used for Preimplantation Genetic Diagnosis (PGD). Reprogenetics is the only laboratory in the United States with clinical experience using this technique.
Recent articles on both techniques can be found in our news section.